G. Peter

550 total citations
36 papers, 465 citations indexed

About

G. Peter is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, G. Peter has authored 36 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Physiology. Recurrent topics in G. Peter's work include Muscle metabolism and nutrition (8 papers), Diet and metabolism studies (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). G. Peter is often cited by papers focused on Muscle metabolism and nutrition (8 papers), Diet and metabolism studies (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). G. Peter collaborates with scholars based in Germany, Colombia and United States. G. Peter's co-authors include H. J. Hohorst, Georg Voelcker, Hohorst Hj, T. Wagner, J. Draeger, Robert F. Struck, Thomas Kronbach, Klaus Wessel, J. Engel and Róbert Hermann and has published in prestigious journals such as Drug and Alcohol Dependence, Drug Metabolism and Disposition and Advances in experimental medicine and biology.

In The Last Decade

G. Peter

34 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Peter Germany	13	148	109	85	79	52	36	465
T. Facchinetti Italy	12	253 1.7×	66 0.6×	25 0.3×	25 0.3×	50 1.0×	18	501
J.M. Rideout United Kingdom	13	344 2.3×	151 1.4×	20 0.2×	26 0.3×	27 0.5×	34	617
Erdoğan Ertürk United States	12	165 1.1×	56 0.5×	31 0.4×	60 0.8×	77 1.5×	17	467
Moo Je Sung United States	12	121 0.8×	70 0.6×	26 0.3×	60 0.8×	25 0.5×	16	479
M A Leo United States	16	339 2.3×	467 4.3×	33 0.4×	157 2.0×	62 1.2×	25	975
Alf Wallin Sweden	11	185 1.3×	33 0.3×	17 0.2×	89 1.1×	45 0.9×	15	377
Susan E. Donohue United States	17	507 3.4×	131 1.2×	20 0.2×	40 0.5×	43 0.8×	26	850
E. Schillinger Germany	18	243 1.6×	29 0.3×	168 2.0×	68 0.9×	43 0.8×	58	1.1k
S M Kalman United States	12	155 1.0×	161 1.5×	69 0.8×	21 0.3×	16 0.3×	17	532
N. Kitrossky Israel	7	107 0.7×	72 0.7×	45 0.5×	13 0.2×	25 0.5×	9	359

Countries citing papers authored by G. Peter

Since Specialization

Citations

This map shows the geographic impact of G. Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Peter more than expected).

Fields of papers citing papers by G. Peter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Peter. The network helps show where G. Peter may publish in the future.

Co-authorship network of co-authors of G. Peter

This figure shows the co-authorship network connecting the top 25 collaborators of G. Peter. A scholar is included among the top collaborators of G. Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Peter. G. Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peter, G., et al.. (2001). New metabolic pathways of alpha-lipoic acid.. PubMed. 29(6). 855–62. 63 indexed citations

Peter, G., et al.. (2000). Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs1. Drug Metabolism and Disposition. 28(1). 10–20. 14 indexed citations

Niebch, G, et al.. (1991). Metabolic fate of the novel antihypertensive drug naftopidil.. PubMed. 41(10). 1027–32. 6 indexed citations

Schaefer, Roland M., et al.. (1989). Catabolic Effects of Ethanol in Chronically Uremic Rats. The Nephron journals/Nephron journals. 51(1). 67–72. 3 indexed citations

Teschner, Markus, et al.. (1989). Independence of enhanced protein catabolism from glucocorticoids in chronically uremic rats. Research in Experimental Medicine. 189(5). 339–345. 2 indexed citations

Schaefer, R. M., Mike Moser, Peter Kulzer, et al.. (1988). Hormonal Regulation of Muscle Protein Catabolism in Acutely Uremic Rats: Effect of Adrenalectomy and Parathyroidectomy. Advances in experimental medicine and biology. 240. 257–266. 1 indexed citations

Teschner, Markus, et al.. (1988). Eglin C Fails to Reduce Catabolism in Acutely Uremic Rats. Advances in experimental medicine and biology. 240. 331–337. 1 indexed citations

Teschner, Markus, Roland M. Schaefer, Florian Weißinger, et al.. (1988). Chronic Ethanol Ingestion Enhances Catabolism and Muscle Protease Activity in Acutely Uremic Rats. The Nephron journals/Nephron journals. 50(4). 338–344. 8 indexed citations

Schaefer, Roland M., et al.. (1988). Evidence for the Role of Proteinases in Uremic Catabolism. Advances in experimental medicine and biology. 240. 323–329.

10.

Schaefer, Roland M., J. Weipert, Mike Moser, et al.. (1988). Reduction of Urea Generation and Muscle Protein Degradation by Adrenalectomy in Acutely Uremic Rats. The Nephron journals/Nephron journals. 48(2). 149–153. 9 indexed citations

11.

Teschner, Markus, et al.. (1988). Reduction of muscle protein degradation by leupeptin in acutely uremic rats.. PubMed. 14(5). 308–12. 3 indexed citations

12.

Schaefer, Roland M., et al.. (1987). Evidence for Reduced Catabolism by the Antiglucocorticoid RU 38486 in Acutely Uremic Rats. American Journal of Nephrology. 7(2). 127–131. 9 indexed citations

13.

Heidland, A., Roland M. Schaefer, J. Weipert, et al.. (1987). Catabolism in Acute Renal Failure: Importance of Glucocorticoids and Lysosomal Enzymes. Advances in experimental medicine and biology. 212. 41–55. 1 indexed citations

14.

Nickel, B, et al.. (1986). Fenetylline: New results on pharmacology, metabolism and kinetics. Drug and Alcohol Dependence. 17(2-3). 235–257. 19 indexed citations

15.

Peter, G., et al.. (1980). Does acrolein contribute to the cytotoxicity of cyclophosphamide?. Journal of Cancer Research and Clinical Oncology. 98(2). 119–126. 28 indexed citations

16.

Peter, G. & H. J. Hohorst. (1979). Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides. Cancer Chemotherapy and Pharmacology. 3(3). 181–8. 26 indexed citations

17.

Wagner, Thomas, et al.. (1977). Characterization and quantitative estimation of activated cyclophosphamide in blood and urine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(8 Pt 1). 2592–6. 32 indexed citations

18.

Hj, Hohorst, et al.. (1976). The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.. PubMed. 60(4). 309–15. 57 indexed citations

19.

Peter, G., T. Wagner, & H. J. Hohorst. (1976). Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.. PubMed. 60(4). 429–35. 32 indexed citations

20.

Peter, G., et al.. (1974). [Biochemical aspects of amino acid metabolism in Psoriasis vulgaris (author's transl)].. PubMed. 28(7). 446–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact